Euroapi Company Header Euroapi Company Header

X

Find Basimglurant manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Basimglurant
Also known as: 802906-73-6, Ctep derivative, Rg7090, 2-chloro-4-((1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl)ethynyl)pyridine, Rg-7090, Ro4917523
Molecular Formula
C18H13ClFN3
Molecular Weight
325.8  g/mol
InChI Key
UPZWINBEAHDTLA-UHFFFAOYSA-N
FDA UNII
3110E3AO8S

Basimglurant has been used in trials studying the diagnostic and treatment of Depression, Fragile X Syndrome, and Major Depressive Disorder.
1 2D Structure

Basimglurant

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethylimidazol-4-yl]ethynyl]pyridine
2.1.2 InChI
InChI=1S/C18H13ClFN3/c1-12-17(8-3-14-9-10-21-18(19)11-14)22-13(2)23(12)16-6-4-15(20)5-7-16/h4-7,9-11H,1-2H3
2.1.3 InChI Key
UPZWINBEAHDTLA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl
2.2 Other Identifiers
2.2.1 UNII
3110E3AO8S
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl)pyridine

2. Ro4917523

2.3.2 Depositor-Supplied Synonyms

1. 802906-73-6

2. Ctep Derivative

3. Rg7090

4. 2-chloro-4-((1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl)ethynyl)pyridine

5. Rg-7090

6. Ro4917523

7. Ro-4917523

8. 2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethylimidazol-4-yl]ethynyl]pyridine

9. Noe-101

10. 3110e3ao8s

11. 1034442-21-1 (free Base)

12. 2-chloro-4-(2-(1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl)ethynyl)pyridine

13. Pyridine, 2-chloro-4-(2-(1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl)ethynyl)-

14. 1034442-21-1

15. Basimglurant [usan:inn]

16. Unii-3110e3ao8s

17. 2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl]ethynyl]pyridine

18. Basimglurant [inn]

19. Rg7090basimglurant

20. Rg 7090

21. Ro 4917523

22. Basimglurant (usan/inn)

23. Basimglurant [usan]

24. Basimglurant [who-dd]

25. Schembl560590

26. Gtpl9309

27. Chembl3301626

28. Dtxsid801025734

29. Hms3741c15

30. Bcp15864

31. Zinc6716839

32. Bdbm50071374

33. Mfcd25976719

34. Rg7090rg7090

35. Compound 2 [pmid: 25565255]

36. Cs-3388

37. Db11833

38. Ncgc00390716-02

39. Ac-35776

40. As-51978

41. Hy-15446

42. Ds-015787

43. D10864

44. P14045

45. A916083

46. Q18209947

47. 1-(4-fluorophenyl)-4-[(2-chloro-4-pyridyl)ethynyl]-2,5-dimethyl-1h-imidazole

48. 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl]-pyridine

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 325.8 g/mol
Molecular Formula C18H13ClFN3
XLogP34.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass325.0782033 g/mol
Monoisotopic Mass325.0782033 g/mol
Topological Polar Surface Area30.7 Ų
Heavy Atom Count23
Formal Charge0
Complexity465
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY